A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone

PURPOSE: The aim of this study was to identify a noninvasive urinary marker for prostate cancer (PCa) diagnosis and to validate the clinical performance of this novel urinary mRNA signature using the droplet digital polymerase chain reaction (ddPCR) approach. MATERIALS AND METHODS: A gene expression...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Investig Clin Urol
Auteurs principaux: Kang, Ho Won, Lee, Hee Youn, Byun, Young Joon, Jeong, Pildu, Yoon, Jin Sun, Kim, Dong Ho, Kim, Won Tae, Kim, Yong-June, Lee, Sang-Cheol, Yun, Seok Joong, Kim, Wun-Jae
Format: Artigo
Langue:Inglês
Publié: The Korean Urological Association 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329636/
https://ncbi.nlm.nih.gov/pubmed/32665998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2020.61.4.411
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires